NuVasive Announces Conference Call and Webcast of Second Quarter 2022 Results
On July 18, 2022, NuVasive (NASDAQ: NUVA) announced it will release its second quarter financial results on August 3, 2022, post-market. A conference call to discuss the results will take place at 4:30 PM ET, accessible via specific dial-in numbers or via a live webcast on their Investor Relations page. NuVasive, a leader in spine technology, boasts over $1 billion in net sales, offering innovative surgical solutions across more than 50 countries. For detailed information, visit www.nuvasive.com.
- NuVasive is a leader in spine technology with over $1 billion in net sales.
- The company's comprehensive portfolio includes advanced, less-invasive surgical solutions.
- None.
SAN DIEGO, July 18, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its second quarter results on Wednesday, August 3, 2022, after the close of the market.
NuVasive will hold a conference call on Wednesday, August 3, 2022, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the second quarter ended June 30, 2022. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call and supplemental financial information of our second quarter 2022 results will be available on the Investor Relations page of our website at www.nuvasive.com. An audio replay of the call will be available until August 10, 2022. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13731013. In addition, the webcast will be archived on NuVasive's website.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than
Forward-Looking Statements
NuVasive cautions you that statements included in this news release and the associated conference call and webcast that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's net sales or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating net sales or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-second-quarter-2022-results-301587747.html
SOURCE NuVasive, Inc.
FAQ
When will NuVasive release its second quarter 2022 financial results?
What time is the NuVasive conference call for Q2 2022 results?
How can I access NuVasive's second quarter results conference call?
Where can I find the webcast for NuVasive's Q2 2022 results?
